Src-kinase inhibitors sensitize human cells of myeloid origin to Toll-like-receptor–induced interleukin 12 synthesis

Src-kinase inhibitors hold great potential as targeted therapy against malignant cells. However, such inhibitors may also affect nonmalignant cells and cause pronounced off-target effects. We investigated the role of the dual kinase inhibitor dasatinib on human myeloid cells. Dasatinib is clinically...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Wölfl, Matthias, Schwinn, Stefanie, Yoo, Young-Eun, Reß, Marie L., Braun, Matthias, Chopra, Martin, Schreiber, Susanne C., Ayala, Victor I., Ohlen, Claes, Eyrich, Matthias, Beilhack, Andreas, Schlegel, Paul G.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2013
Teme:
Immunobiology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3744989/
https://ncbi.nlm.nih.gov/pubmed/23836556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-03-488072
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items